Cargando…
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection
BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759915/ https://www.ncbi.nlm.nih.gov/pubmed/35035611 http://dx.doi.org/10.1155/2022/6478434 |
_version_ | 1784633208228282368 |
---|---|
author | Bulfoni, Michela Sozio, Emanuela Marcon, Barbara De Martino, Maria Cesselli, Daniela De Carlo, Chiara Martinella, Romina Migotti, Angelica Vania, Eleonora Zanus-Fortes, Agnese De Piero, Jessica Nencioni, Emanuele Tascini, Carlo Isola, Miriam Curcio, Francesco |
author_facet | Bulfoni, Michela Sozio, Emanuela Marcon, Barbara De Martino, Maria Cesselli, Daniela De Carlo, Chiara Martinella, Romina Migotti, Angelica Vania, Eleonora Zanus-Fortes, Agnese De Piero, Jessica Nencioni, Emanuele Tascini, Carlo Isola, Miriam Curcio, Francesco |
author_sort | Bulfoni, Michela |
collection | PubMed |
description | BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, offer clear, practical, and logistical advantages but due to a lack of collection, transport, and storage solutions, high-throughput saliva-based laboratory tests are difficult to scale up as a screening or diagnostic tool. With this study, we aimed to validate an intralaboratory molecular detection method for SARS-CoV-2 on saliva samples collected in a new storage saline solution, comparing the results to NP swabs to determine the difference in sensitivity between the two tests. METHODS: In this study, 156 patients (cases) and 1005 asymptomatic subjects (controls) were enrolled and tested simultaneously for the detection of the SARS-CoV-2 viral genome by RT-PCR on both NP swab and saliva samples. Saliva samples were collected in a preservative and inhibiting saline solution (Biofarma Srl). Internal method validation was performed to standardize the entire workflow for saliva samples. RESULTS: The identification of SARS-CoV-2 conducted on saliva samples showed a clinical sensitivity of 95.1% and specificity of 97.8% compared to NP swabs. The positive predictive value (PPV) was 81% while the negative predictive value (NPV) was 99.5%. Test concordance was 97.6% (Cohen's Kappa = 0.86; 95% CI 0.81-0.91). The LoD of the test was 5 viral copies for both samples. CONCLUSIONS: RT-PCR assays conducted on a stored saliva sample achieved similar performance to those on NP swabs, and this may provide a very effective tool for population screening and diagnosis. Collection of saliva in a stabilizing solution makes the test more convenient and widely available; furthermore, the denaturing properties of the solution reduce the infective risks belonging to sample manipulation. |
format | Online Article Text |
id | pubmed-8759915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-87599152022-01-15 Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection Bulfoni, Michela Sozio, Emanuela Marcon, Barbara De Martino, Maria Cesselli, Daniela De Carlo, Chiara Martinella, Romina Migotti, Angelica Vania, Eleonora Zanus-Fortes, Agnese De Piero, Jessica Nencioni, Emanuele Tascini, Carlo Isola, Miriam Curcio, Francesco Dis Markers Research Article BACKGROUND: Since the beginning of the pandemic, clinicians and researchers have been searching for alternative tests to improve the screening and diagnosis of the SARS-CoV-2 infection. Currently, the gold standard for virus identification is the nasopharyngeal (NP) swab. Saliva samples, however, offer clear, practical, and logistical advantages but due to a lack of collection, transport, and storage solutions, high-throughput saliva-based laboratory tests are difficult to scale up as a screening or diagnostic tool. With this study, we aimed to validate an intralaboratory molecular detection method for SARS-CoV-2 on saliva samples collected in a new storage saline solution, comparing the results to NP swabs to determine the difference in sensitivity between the two tests. METHODS: In this study, 156 patients (cases) and 1005 asymptomatic subjects (controls) were enrolled and tested simultaneously for the detection of the SARS-CoV-2 viral genome by RT-PCR on both NP swab and saliva samples. Saliva samples were collected in a preservative and inhibiting saline solution (Biofarma Srl). Internal method validation was performed to standardize the entire workflow for saliva samples. RESULTS: The identification of SARS-CoV-2 conducted on saliva samples showed a clinical sensitivity of 95.1% and specificity of 97.8% compared to NP swabs. The positive predictive value (PPV) was 81% while the negative predictive value (NPV) was 99.5%. Test concordance was 97.6% (Cohen's Kappa = 0.86; 95% CI 0.81-0.91). The LoD of the test was 5 viral copies for both samples. CONCLUSIONS: RT-PCR assays conducted on a stored saliva sample achieved similar performance to those on NP swabs, and this may provide a very effective tool for population screening and diagnosis. Collection of saliva in a stabilizing solution makes the test more convenient and widely available; furthermore, the denaturing properties of the solution reduce the infective risks belonging to sample manipulation. Hindawi 2022-01-07 /pmc/articles/PMC8759915/ /pubmed/35035611 http://dx.doi.org/10.1155/2022/6478434 Text en Copyright © 2022 Michela Bulfoni et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bulfoni, Michela Sozio, Emanuela Marcon, Barbara De Martino, Maria Cesselli, Daniela De Carlo, Chiara Martinella, Romina Migotti, Angelica Vania, Eleonora Zanus-Fortes, Agnese De Piero, Jessica Nencioni, Emanuele Tascini, Carlo Isola, Miriam Curcio, Francesco Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title | Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title_full | Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title_fullStr | Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title_full_unstemmed | Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title_short | Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection |
title_sort | validation of a saliva-based test for the molecular diagnosis of sars-cov-2 infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759915/ https://www.ncbi.nlm.nih.gov/pubmed/35035611 http://dx.doi.org/10.1155/2022/6478434 |
work_keys_str_mv | AT bulfonimichela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT sozioemanuela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT marconbarbara validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT demartinomaria validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT cessellidaniela validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT decarlochiara validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT martinellaromina validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT migottiangelica validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT vaniaeleonora validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT zanusfortesagnese validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT depierojessica validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT nencioniemanuele validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT tascinicarlo validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT isolamiriam validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection AT curciofrancesco validationofasalivabasedtestforthemoleculardiagnosisofsarscov2infection |